Danielle Hughes, MD
Critical Care Medicine · Belleville, ILNPI 1114414935
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (48.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Intuitive Surgical accounts for 62.1% of it on its own, with 20 other manufacturers making up the rest. 2025 is the largest year on record at $4,622, more than ten times the $58 reported in 2023.
Across 63 payments — averaging $82.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$3K
- Olympus Corporation Of The Americas$914
- GSK$209
- Eagle Pharmaceuticals, Inc.$125
- AstraZeneca$105
- Sanofi$87
- plus $529 from 15 others
What the payments were for
- Travel & lodging$1,28525%
- Food & beverage$1,41527%
- Education$2,50048%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 9 | $3,230 |
| Olympus Corporation Of The Americas | 7 | $914 |
| GSK | 11 | $209 |
| Eagle Pharmaceuticals, Inc. | 1 | $125 |
| AstraZeneca | 6 | $105 |
| Sanofi | 4 | $87 |
| Insmed, Inc. | 4 | $75 |
| Shionogi Inc | 3 | $65 |
| Bayer | 1 | $58 |
| Axsome Therapeutics, Inc. | 4 | $55 |
| United Therapeutics Corporation | 2 | $47 |
| Verona Pharma, Inc. | 2 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $29 |
| Boehringer Ingelheim | 1 | $24 |
| Monaghan Medical Corporation | 1 | $21 |
| Grifols USA, LLC | 1 | $21 |
| La Jolla Pharmaceutical Company | 1 | $20 |
| Vifor Pharma, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $20 |
| Viatris Specialty LLC | 1 | $18 |
| Baxter Healthcare | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$3,022
- BYFAVO$125
How this compares
$5,200 in reported general payments places this provider in the 85th percentile of 281 critical care medicine providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XolairOmalizumab | 24 | $54,062 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 31 | $14,614 |
| Spiriva RespimatTiotropium Bromide | 15 | $9,728 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 12 | $7,308 |
| Advair HfaFluticasone Propion/Salmeterol | 12 | $7,267 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $3,768 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 42 | $823 |
| Azithromycin | 16 | $366 |
| Prednisone | 23 | $123 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimStiolto Respimat, Spiriva Respimat | $24 | $24,34346 claims |
| GSKAnoro Ellipta | $209 | $7,30812 claims |
| AstraZenecaSymbicort | $105 | $3,76811 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 281 critical care medicine providers in Illinois.
Other critical care medicine in Belleville
- Salik ChoudharyBelleville$4K
- Zachary YoungBelleville$3K
- Brian ReichardtO Fallon$892K
- Michael CutticaChicago$402K
- Daniel DillingMaywood$208K
- Israel RubinsteinChicago$107K
- John RickelmanQuincy$90K
- Abbas Al-QamariChicago$40K
- Husam NayefPalos Park$24K
- Nureain MirzaOak Lawn$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.